Clinical Trials Directory

Trials / Unknown

UnknownNCT05585060

The Changes in End Expiratory Lung Impedence Measured by EIT and End Expiratory Lung Volume Measured by Passive Expiratory in Controlled Mechanical Ventilated Exacerbation COPD Patients

The Relevance and Consistency Study of Changes in End Expiratory Lung Impedence Measured by EIT and End Expiratory Lung Volume Measured by Passive Expiratory in Controlled Mechanical Ventilated Exacerbation COPD Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
The First Affiliated Hospital of Guangzhou Medical University · Academic / Other
Sex
All
Age
35 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The pathophysiological characteristics of respiratory failure on exacerbation of chronic pulmonary obstructive disease are the rapid deteriorate of respiratory symptoms, combined with aggravated flow limitation, gas trapping, dynamic pulmonary hyperinflation (DPH), therefore the intrinsic PEEP (PEEPi) increases. It is worthwhile to explore bedside methods to quantify the changes in dynamic pulmonary hyperinflation to guide safe and effective mechanical ventilation in airflow limited patients.

Detailed description

The study hypothesizes that the electrical impedence tomography (EIT) measured the changes of end expiratory lung impedence (△EELI) could accurately predict the changes of end expiratory lung volume (△EELV) measured by passive expiratory in controlled mechanical ventilated exacerbation COPD patients. The research intended to conduct a research to explore the relationship between △EELI and △EELV induced by external PEEP changes in ventilated exacerbation COPD patients.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTthe changes of end expiratory lung impedencethe changes of end expiratory lung impedence measured by EIT
DIAGNOSTIC_TESTthe changes of end expiratory lung volumethe changes of end expiratory lung volume measured by apnea method

Timeline

Start date
2022-09-13
Primary completion
2023-10-08
Completion
2023-10-08
First posted
2022-10-18
Last updated
2022-11-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05585060. Inclusion in this directory is not an endorsement.